ProKidney Corp. targets diabetic CKD with Rilparencel and expects Q2 2027 eGFR slope data for accelerated approval. Find out ...

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...

A Spanish study wipes out pancreatic cancer in mice, causing viral claims of a cure. Breakthrough science or false hope?

As images of Barbacid circulated alongside news of the study, parts of social media fixated not on the science but on his ...

Spanish researchers achieved complete pancreatic tumor elimination in mice using a triple-drug strategy targeting KRAS and ...

Spanish scientist Dr Mariano Barbacid and his team have developed a targeted therapy that eliminated pancreatic tumours in mice, marking a significant breakthrough.

Spanish researchers report a major pancreatic cancer breakthrough in mice, with a triple-drug therapy eliminating tumours by targeting the KRAS pathway, raising hopes for future human trials.

Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...

Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...

Epithelial–mesenchymal transition (EMT) is a biological process that involves the transformation of epithelial cells into ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...